# Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer

> **NCT01962324** · NA · COMPLETED · sponsor: **Umeå University** · enrollment: 85 (actual)

## Conditions studied

- Prostatic Neoplasms
- Lymphatic Metastasis

## Interventions

- **RADIATION:** SIB Dose-Escalation Radiotherapy

## Key facts

- **NCT ID:** NCT01962324
- **Lead sponsor:** Umeå University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2023-05-09
- **Final completion:** 2023-05-09
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2024-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01962324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01962324, "Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01962324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*